Home E-Weekly March 27, 2018

News & Notes

Published: March 27, 2018

  • "Ultra-restrictive" protocol significantly reduces opioid prescriptions, not post-op pain scoresPhysicians reduced the number of opioid tablets they prescribed by 97% in ambulatory or minimally invasive procedures and saw no difference in post-op pain scores, a prospective study conducted at Roswell Park Comprehensive Cancer Center found. The average number of opioid tablets gynecologic surgeons prescribed went from 31.7 to 3.5 at the Center after implementing this restrictive protocol.
  • Lap band surgery reduces knee pain Overweight patients who undergo lap band surgery to shed excess pounds also experience relief from arthritic knee pain, says research published in the journal Seminars in Arthritis and Rheumatism. The study's authors say the knee-preserving benefits of weight-loss surgery are more pronounced in younger patients, a finding that suggests obese individuals should opt to have lap bands placed sooner rather than later.
  • FDA updates statistics linking breast implants to cancer The FDA says 414 women with breast implants have developed anaplastic large-cell lymphoma (ALCL), a rare type of non-Hodgkin T-cell lymphoma associated with breast implants. Nine of those patients have died. The FDA first identified a possible association between breast implants and the development of ALCL in 2011.
New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Jury: Orthopedic Surgeon's Routine of Performing 14 Concurrent Surgeries a Day Negligent

$2M verdict in 'assembly line' surgery case.

Music Is as Good as Sedative in Calming Nerves Before Surgery

Study finds listening to the "most relaxing song on Earth" before getting a nerve block reduces anxiety as well as Versed.

Federal Court Dismisses More Than 5,000 Lawsuits Against 3M's Patient Warming System

The ruling, which follows a recent Minnesota appeals court dismissal of suits against 3M, is the latest in a 6-year legal battle.